These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37168679)

  • 1. Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.
    Yang X; Ma Z; Lian P; Xu Y; Cao X
    Front Mol Neurosci; 2023; 16():1172197. PubMed ID: 37168679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.
    Brady ST; Morfini GA
    Neurobiol Dis; 2017 Sep; 105():273-282. PubMed ID: 28411118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.
    Theunissen F; West PK; Brennan S; Petrović B; Hooshmand K; Akkari PA; Keon M; Guennewig B
    Transl Neurodegener; 2021 Nov; 10(1):46. PubMed ID: 34789332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases.
    Chen XJ; Xu H; Cooper HM; Liu Y
    Sci China Life Sci; 2014 Apr; 57(4):372-7. PubMed ID: 24664850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of axonal transport in neurodegenerative diseases.
    De Vos KJ; Grierson AJ; Ackerley S; Miller CC
    Annu Rev Neurosci; 2008; 31():151-73. PubMed ID: 18558852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.
    Brunden KR; Lee VM; Smith AB; Trojanowski JQ; Ballatore C
    Neurobiol Dis; 2017 Sep; 105():328-335. PubMed ID: 28012891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics.
    White JA; Banerjee R; Gunawardena S
    Mar Drugs; 2016 May; 14(5):. PubMed ID: 27213408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
    Gao J; Wang L; Liu J; Xie F; Su B; Wang X
    Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.
    Brunden KR; Trojanowski JQ; Smith AB; Lee VM; Ballatore C
    Bioorg Med Chem; 2014 Sep; 22(18):5040-9. PubMed ID: 24433963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs in Neurodegenerative Diseases.
    Grasso M; Piscopo P; Crestini A; Confaloni A; Denti MA
    Exp Suppl; 2015; 106():151-169. PubMed ID: 26608203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?
    De Vos KJ; Hafezparast M
    Neurobiol Dis; 2017 Sep; 105():283-299. PubMed ID: 28235672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde axonal transport: pathways to cell death?
    Perlson E; Maday S; Fu MM; Moughamian AJ; Holzbaur EL
    Trends Neurosci; 2010 Jul; 33(7):335-44. PubMed ID: 20434225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miro (Mitochondrial Rho GTPase), a key player of mitochondrial axonal transport and mitochondrial dynamics in neurodegenerative diseases.
    Panchal K; Tiwari AK
    Mitochondrion; 2021 Jan; 56():118-135. PubMed ID: 33127590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagosome dynamics in neurodegeneration at a glance.
    Wong YC; Holzbaur EL
    J Cell Sci; 2015 Apr; 128(7):1259-67. PubMed ID: 25829512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
    Panchal K; Tiwari AK
    Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration.
    Argueti-Ostrovsky S; Alfahel L; Kahn J; Israelson A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.